McElwaine P, McCormack J, Brennan C, Coetzee H, Cotter P, Doyle R, Hickey A, Horgan F, Loughnane C, Macey C, Marsden P, McCabe D, Mulcahy R, Noone I, Shelley E, Stapleton T, Williams D, Kelly P, Harbison J
National Clinical Programme for Stroke, Health Service Executive, Dublin, Ireland.
Trinity College, University of Dublin, Dublin, Ireland.
Ir J Med Sci. 2018 May;187(2):275-280. doi: 10.1007/s11845-017-1661-5. Epub 2017 Jul 17.
In the setting of a national audit of acute stroke services, we examined the delivery of thrombolytic therapy for ischaemic stroke and whether current practice was achieving safe outcomes and consistent delivery for patients.
Data obtained from the recent national stroke audit was compared against previous Irish audit, the most recent SSNAP UK stroke audit and the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) study.
Thrombolysis was provided in 27 acute hospitals throughout Ireland during the period assessed with 82% (22/27) providing 24/7 access, the remaining sites using redirect policies. Decision to thrombolyse was made by stroke trained consultants in 63% (17/27) of units, with general physicians and emergency medicine consultants covering the other units. Thrombolysis rate for non-haemorrhagic stroke was 11% (n = 80/742, CI 95% ±2.23) versus a 1% rate in the 2008 audit. Sites receiving patients through a redirect policy had the highest thrombolysis rate, an average of 24%. Nearly 30% of cases were thrombolysed on the weekend. Eighty-three percent of cases were managed in a stroke unit at some time during admission versus 54% of the national total cases. Thirty-seven percent of patients were ≥80 years old. The mortality rate was 11.3% versus the national mortality rate for non-thrombolysed ischaemic strokes of 10% (p > 0.5), and this is comparable to the SITS-MOST 2007 study 3-month mortality rate of 11.3% (p > 0.5).
Stroke thrombolysis is being effectively and safely provided in acute stroke services in Ireland despite regular involvement of non-specialist staff. There is still potential to improve thrombolysis rate.
在一项全国急性中风服务审计中,我们研究了缺血性中风溶栓治疗的实施情况,以及当前的治疗方法是否能为患者带来安全的治疗效果和持续一致的治疗。
将近期全国中风审计获得的数据与爱尔兰之前的审计、英国最新的SSNAP中风审计以及中风溶栓安全实施监测研究(SITS - MOST)进行比较。
在评估期间,爱尔兰27家急性医院提供了溶栓治疗,其中82%(22/27)的医院提供全天候服务,其余医院采用转诊政策。63%(17/27)的科室由经过中风培训的顾问决定是否进行溶栓治疗,其他科室由普通内科医生和急诊医学顾问负责。非出血性中风的溶栓率为11%(n = 80/742,95%置信区间±2.23),而2008年审计中的溶栓率为1%。通过转诊政策接收患者的医院溶栓率最高,平均为24%。近30%的病例在周末进行了溶栓治疗。83%的病例在入院期间的某个时间在中风单元接受治疗,而全国总病例数的这一比例为54%。37%的患者年龄≥80岁。死亡率为11.3%,与全国非溶栓缺血性中风的死亡率10%相比(p > 0.5),这与SITS - MOST 2007研究中3个月的死亡率11.3%相当(p > 0.5)。
尽管有非专科工作人员的定期参与,但爱尔兰的急性中风服务中仍能有效且安全地提供中风溶栓治疗。提高溶栓率仍有潜力。